(Q35886715)

10 August 2017

1 reference

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Neuronal pathology in Parkinson's disease. (English)

1 reference

10 August 2017

1 reference

1

Jörg B Schulz

1 reference

10 August 2017

Björn H Falkenburger

2

1 reference

10 August 2017

publication date

8 September 2004

1 reference

10 August 2017

published in

Cell and Tissue Research

1 reference

10 August 2017

volume

318

1 reference

10 August 2017

issue

1

1 reference

10 August 2017

page(s)

135-147

1 reference

Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC

10 August 2017

cites work

1 reference

4 November 2023

https://opencitations.net/index/coci/api/v1/citations/10.1038/20959

The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

On the question of apoptosis in the parkinsonian substantia nigra

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

The neuroprotective effects of CGP 3466B in the best in vivo model of Parkinson's disease, the bilaterally MPTP-treated rhesus monkey

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Histochemical detection of apoptosis in Parkinson's disease.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Dopaminergic toxicity after the stereotaxic administration of the 1-methyl-4-phenylpyridinium ion (MPP+) to rats

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

The biochemistry of apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

The ubiquitin pathway in Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase isoforms during neuronal apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Cascade of caspase activation in potassium-deprived cerebellar granule neurons: targets for treatment with peptide and protein inhibitors of apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

GAPDH knockdown rescues mesencephalic dopaminergic neurons from MPP+ -induced apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

The ubiquitin system for protein degradation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Overexpression of glyceraldehyde-3-phosphate dehydrogenase is involved in low K+-induced apoptosis but not necrosis of cultured cerebellar granule cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Molecular pathogenesis of movement disorders: are protein aggregates a common link in neuronal degeneration?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Evidence that glyceraldehyde-3-phosphate dehydrogenase is involved in age-induced apoptosis in mature cerebellar neurons in culture.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridinum-induced toxicity of cultured fetal rat mesencephalic dopamine neurons

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

The X-linked inhibitor of apoptosis (XIAP) prevents cell death in axotomized CNS neurons in vivo.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

BAX-dependent transport of cytochrome c reconstituted in pure liposomes

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

IAP family proteins--suppressors of apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Adenovirus-mediated gene transfer of inhibitors of apoptosis protein delays apoptosis in cerebellar granule neurons.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

The effect of microglia on embryonic dopaminergic neuronal survival in vitro: diffusible signals from neurons and glia change microglia from neurotoxic to neuroprotective.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Glutathione, oxidative stress and neurodegeneration

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Failure of the ubiquitin-proteasome system in Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

BAX is required for neuronal death after trophic factor deprivation and during development

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Low concentrations of 1-methyl-4-phenylpyridinium ion induce caspase-mediated apoptosis in human SH-SY5Y neuroblastoma cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Dopamine turnover and glutathione oxidation: implications for Parkinson disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Proteasomal function is impaired in substantia nigra in Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Cell death and apoptosis regulating proteins in Parkinson's disease--a cautionary note

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Apoptosis in neurodegenerative disorders

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-cultures

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Neuroprotection by the inhibition of apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Parkinson's disease: one biochemical pathway to fit all genes?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Astrocyte-enhanced neuronal survival is mediated by scavenging of extracellular reactive oxygen species

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Tyrosine-to-cysteine modification of human alpha-synuclein enhances protein aggregation and cellular toxicity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Systemic administration of the propargylamine CGP 3466B prevents behavioural and morphological deficits in rats with 6-hydroxydopamine-induced lesions in the substantia nigra.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Transgenic mice neuronally expressing baculoviral p35 are resistant to diverse types of induced apoptosis, including seizure-associated neurodegeneration

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Structure/function of alpha-synuclein in health and disease: rational development of animal models for Parkinson's and related diseases

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Neuropathology of Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

CGP 3466 protects dopaminergic neurons in lesion models of Parkinson's disease.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Involvement of a caspase-3-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Role of mitochondria in oxidative stress and ageing

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

The pro-apoptotic proteins, Bid and Bax, cause a limited permeabilization of the mitochondrial outer membrane that is enhanced by cytosol

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Transgenic mice expressing a dominant negative mutant interleukin-1beta converting enzyme show resistance to MPTP neurotoxicity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

New animal models for Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Experimental models of Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Fine Structure and Biochemical Mechanisms Underlying Nigrostriatal Inclusions and Cell Death after Proteasome Inhibition

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Parkinson's disease: loss of neurons from the ventral tegmental area contralateral to therapeutic surgical lesions

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Mitochondrial complex I deficiency in Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Nuclear translocation of GAPDH-GFP fusion protein during apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00441-004-0954-Y

Identifiers

DOI

10.1007/S00441-004-0954-Y

1 reference

10 August 2017

1 reference